28th Feb 2007 11:47
ABCAM Plc28 February 2007 For immediate release 28 February 2007 ABCAM PLC ("Abcam" or "the Company") Directors' Share Dealings Cambridge UK, 28 February 2007: Abcam plc announces that the following Directorshave sold, to institutional investors, ordinary shares of 1p each in theCompany: Director No. of Date sold Price Subsequent Percentage of shares per beneficial issued share sold share holding capital following saleJonathan Milner 350,000 27 February 2007 275p 9,394,960 27.16% David Cleevely 350,000 27 February 2007 275p 4,704,760 13.60% Tony Kouzarides 200,000 27 February 2007 275p 429,080 1.24% Eddie Powell 60,000 27 February 2007 275p 666,240 1.93% Jim Warwick 40,000 27 February 2007 275p 856,200 2.48% For further information please contact: Abcam + 44 (0) 1223 696000 Jonathan Milner, Chief Executive OfficerEddie Powell, Chief Financial Officer www.abcam.com Numis Securities + 44 (0) 20 7776 1500James Black Buchanan Communications + 44 (0) 20 7466 5000 Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts. Abcamwas admitted to AIM in November 2005 and trades under the ticker symbol ABC.The Company produces and distributes its own and third party produced antibodiesto academic and commercial users throughout the world with product informationprovided and ordering available through the Company's website, www.abcam.com.The antibodies are sold under the Abcam brand name. The Company's vision is tobuild the largest online antibody resource in the world while also ensuring thatthe antibodies are of high quality and commercially viable. Abcam now has anonline catalogue of approximately 29,000 products, most of which are antibodies,from over 200 suppliers supported by up-to-date and detailed technical datasheets, which are created by the Company. The Company currently employs 120staff in its three operating companies. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ABC.L